Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Wesana Health Holdings Inc C.WESA.X

Alternate Symbol(s):  WSNAF

Wesana Health Holdings Inc. is a Canada-based company. The Company is not engaged in any business activities. The Company is looking for new business opportunities.

Recent & Breaking News (CSE:WESA.X)

Wesana Health Announces Restructuring of Promissory Note Receivable

Newsfile November 28, 2023

CSE Bulletin: Symbol Change - Inactive Designation - Wesana Health Holdings Inc. (WESA)

Newsfile July 11, 2023

Wesana Health Announces Closing of Previously Announced SANA-013 Asset Sale

GlobeNewswire July 5, 2023

Wesana Health Announces Voting Results of AGSM

GlobeNewswire June 9, 2023

IIROC Trade Resumption - WESA

Canada NewsWire March 21, 2023

Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery

GlobeNewswire March 21, 2023

IIROC Trading Halt - WESA

Canada NewsWire March 21, 2023

Wesana Health Announces Receipt of Short-Term Loan

GlobeNewswire December 16, 2022

Wesana Announces Sale of Clinic Management Services Organization

GlobeNewswire September 1, 2022

Wesana Announces Second Quarter 2022 Financial Results

GlobeNewswire August 29, 2022

Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

GlobeNewswire June 8, 2022

Wesana Announces First Quarter 2022 Financial Results

GlobeNewswire May 31, 2022

Wesana Health Outlines Accelerated Drug Development Pathway

GlobeNewswire May 10, 2022

Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its Clinics and Other Care Delivery Assets

GlobeNewswire May 5, 2022

Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highlights

GlobeNewswire May 2, 2022

Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat Major Depressive Disorder

GlobeNewswire April 18, 2022

Wesana Health CEO Daniel Carcillo to Speak at Several Leading Investor and Industry Events

GlobeNewswire March 29, 2022

Wesana Health Announces New Findings Indicating Psylocibin Potentiates Impact of an Anti-Depressant

GlobeNewswire March 22, 2022

Wesana Health Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013

GlobeNewswire March 14, 2022

Wesana Provides Updates on Build-out of Third Clinic

GlobeNewswire March 11, 2022